Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers-Reference-Cited by-同舟云学术

Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers

Published:2012-02 Issue:2 Volume:44 Page:89-98
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Hopper J.L.,Jenkins M.A.,Dowty J.G.,Dite G.S.,Apicella C.,Keogh L.,Win A.K.,Young J.P.,Buchanan D.,Walsh M.D.,Rosty C.,Baglietto L.,Severi G.,Phillips K.A.,Wong E.M.,Dobrovic A.,Waring P.,Winship I.,Ramus S.J.,Giles G.G.,Southey M.C.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference59 articles.

1. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes;Antoniou;Br J Cancer,2002

2. Population carrier frequency of hMSH2 and hMLHl mutations;Dunlop;Br J Cancer,2000

3. The search for unaffected individuals with Lynch syndrome: do the endsjustify the means?;Hampel;Cancer Prev Res,2011

4. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families;Levy-Lahad;Am J Hum Genet,1997

5. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary;Van Der Looij;Int J Cancer,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and “BRCA-Like” Status, in Both Blood and Tumour DNA;PLOS ONE;2016-07-27

2. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives;Gut;2014-03-10

3. Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer;Journal of Clinical Oncology;2013-09-10

4. Tumour morphology predicts PALB2 germline mutation status;British Journal of Cancer;2013-06-20

5. Cancer family history triage: a key step in the decision to offer screening and genetic testing;Familial Cancer;2012-12-14